Corporate Governance

Corporate Governance

As a company listed on Nasdaq Copenhagen A/S, Genmab A/S is required to give a statement on how the company addresses the Recommendations for Corporate Governance issued by the Committee on Corporate Governance using the “comply-or-explain” principle. The current Recommendations for Corporate Governance were introduced in December 2020.

Below please find Genmab A/S’ Statutory Report on Corporate Governance according to the Danish Financial Statements Act, Section 107b (in Danish "Lovpligtig redegørelse for virksomhedsledelse, jf. årsregnskabslovens § 107 b").

More information is coming soon.

You are now leaving Genmab.com to go to our collaborator’s website. If you continue, we encourage you to read the website’s privacy and cookie policy.